https://clinicaltrials.gov/ct2/show/NCT04236284
Feb 3rd, 2023 - Chronic pain is one of the most prevalent health conditions among Americans, affecting about a third of the general population. In Gulf War (1990-1991) veterans, chronic pain is even more common, with a prevalence of about 50%. Indeed, the pain-related fibromyalgia diagnosis is part of Gulf War Syndrome and is highly comorbid with other common military service-related health problems such as Po...
https://clinicaltrials.gov/ct2/show/NCT03439449
Feb 3rd, 2023 - The purpose of this study is to determine the value of a detailed medical history, acquired by computer-directed, patient self-entry of data, for efficient disposition of patients presenting to the emergency department (ED) with chest pain and non-diagnostic first ECG and/or serum markers for acute coronary syndrome (ACS). The research questions posed are: will the added data and systems-based ...
https://clinicaltrials.gov/ct2/show/NCT01550575
Feb 3rd, 2023 - This study is a retrospective, multi-center, de-identified patient data review. The study will include multiple independent cohorts to evaluate clinical outcomes in different subgroups.
https://clinicaltrials.gov/ct2/show/NCT04126408
Feb 3rd, 2023 - This is a single site, randomized, sham-controlled, double-blind study assessing the feasibility, safety, tolerability, and efficacy of non-invasive VNS (nVNS) in the treatment of headache in subarachnoid hemorrhage (SAH). The hypothesis is that two-two minute noninvasive stimulations of the cervical branch of the Vagus nerve, every 5 hours, is efficacious in safely reducing headache intensity ...
https://clinicaltrials.gov/ct2/show/NCT04162951
Feb 3rd, 2023 - This prospective randomized controlled study will be carried out on female patients who will be presented for breast surgery in the General Surgery Department in Tanta university hospitals over 3 month duration and 6 months follow up that starts immediately after obtaining ethical committee approval, an informed written consent will be obtained from all the participants, all patients data will ...
https://clinicaltrials.gov/ct2/show/NCT03240588
Feb 3rd, 2023 - The objective of the study is to characterize the relationship between select objective metrics and clinical outcomes in chronic pain patients treated with Boston Scientific commercially approved neurostimulation systems.
https://clinicaltrials.gov/ct2/show/NCT05097729
Feb 3rd, 2023 - Osteoarthritis (OA) pain is one of the most prevalent causes of chronic pain worldwide. Symptoms can last from months to a lifetime, severely impacting patients' quality of life. New strategies - including non-invasive brain stimulation techniques - have shown promise for sustained pain relief, yet evidence on their reliability and efficacy is limited. Apkarian et. al have previously shown that...
https://clinicaltrials.gov/ct2/show/NCT04888494
Feb 3rd, 2023 - In this study the investigators aim to examine the effects of Transcranial Magnetic Stimulation (TMS) on hippocampal network connectivity and pain levels in individuals with chronic low back pain.
https://clinicaltrials.gov/ct2/show/NCT05318729
Feb 3rd, 2023 - Traditionally, occupational therapists have utilized vibration for sensory re-education in compression neuropathies and peripheral nerve injuries. Vibration is also commonly used for desensitization of hypersensitivity following amputation, crush injury, and for hypersensitive scarring. Since the vibration tool is readily available in the hand therapy clinic, vibration analgesia should be furth...
https://clinicaltrials.gov/ct2/show/NCT05325580
Feb 3rd, 2023 - Rate of Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department
https://clinicaltrials.gov/ct2/show/NCT05302063
Feb 3rd, 2023 - The purpose of the study is to evaluate the effects of stimulation parameters on clinical outcomes of Spinal Cord Stimulation (SCS) in the treatment of chronic, intractable limb pain resulting from painful Diabetic Peripheral Neuropathy (pDPN).
https://clinicaltrials.gov/ct2/show/NCT05286112
Feb 3rd, 2023 - The investigators are seeking to develop a combined intervention, MBCT-S/P, to focus on both improving functioning and mitigating suicide risk in veterans with chronic pain. The investigators plan to test the new manual's feasibility and acceptability in a sample of veterans experiencing chronic pain and suicidal ideation. Participants will be randomized to either the MBCT-S/P condition (n=38) ...
https://clinicaltrials.gov/ct2/show/NCT05406219
Feb 3rd, 2023 - Researchers are looking for a better way to treat people who have inflammatory conditions. Inflammatory conditions may result from an increased activation of the body's natural defenses (the immune system) and are characterized by swelling, redness, heat, and pain. The study treatment BAY2395840 is under development for use in inflammatory conditions. It works by blocking a protein, the B1 rece...
https://clinicaltrials.gov/ct2/show/NCT05581901
Feb 3rd, 2023 - A multimodal approach and the use of peripheral nerve blocks have improved the treatment of postoperative pain. However, supplemental opioids are predominantly necessary and often continued for months or years after surgery. In fact, continued use of opioids after surgery is an increasing challenge. Consequently, patients undergoing surgery are at risk of experiencing side effects and developin...
https://clinicaltrials.gov/ct2/show/NCT05067257
Feb 3rd, 2023 - This is a global multicenter, randomized Phase 2 study for subjects with advanced cancer experiencing intractable pain to assess the safety and efficacy of a single epidural injection of Resiniferatoxin versus vehicle control. Additional subjects who elect to not enroll but are willing to be followed will comprise a Concurrent Control Group. Subjects will be followed for twelve months.
https://clinicaltrials.gov/ct2/show/NCT05485805
Feb 3rd, 2023 - Researchers are looking for a better way to relieve pain in people, such as after dental surgery. Participants in this study, have had 3 or 4 third molars (cheek teeth) removed and subsequently have moderate to severe tooth pain. The study treatment naproxen sodium suppresses inflammatory pain by reducing inflammation. In the US, naproxen has been marketed since 1976, and naproxen sodium has be...
https://clinicaltrials.gov/ct2/show/NCT05432011
Feb 3rd, 2023 - This study aims to analyze the effect of Pericapsular Nerve Group (PENG) Block combined with lateral femoral cutaneous nerve block vs. PENG block combined with wound infiltration for analgesia after elective hip replacement performed with a posters-lateral approach. Half of participants will receive a PENG Block combined with femoral lateral cutaneous nerve block, while the other half will rece...
https://clinicaltrials.gov/ct2/show/NCT05446597
Feb 3rd, 2023 - The primary objective of this randomized controlled superiority trial (RCT) is to examine if 6-week symptom-specific (1. headache, 2. Dizziness and neck pain, 3. sleep disturbance) treatments initiated in the acute/sub-acute stages (1-3 weeks) following concussion in 13-19 year old participants recruited acutely (<2 weeks) following concussion are superior to a generic 6-week multifaceted treat...
https://clinicaltrials.gov/ct2/show/NCT05475769
Feb 3rd, 2023 - This study aims to create a multicenter registry that will increase the knowledge of nummular headache and assess which treatments are more effective and better tolerated. The study population will be patients with nummular headache who, under the opinion of their responsible neurologists, have required or require preventive treatment, in any of its modalities, oral or injectable.
https://clinicaltrials.gov/ct2/show/NCT05687695
Feb 3rd, 2023 - A randomized controlled trial will be conducted at the Isokinetic laboratory, Faculty of Physical Therapy, Cairo University, to investigate the effect of backward walking training on core muscles strength and endurance, pain severity, and disability level in subjects with NSLBP. Sixty females clinically diagnosed with nonspecific low back pain with age range from 18-45 years will participate in...
